On-Q-ity

On-Q-ity is developing personalized medicine diagnostics that will improve the lives of cancer patients. Through proprietary circulating tumor cell (CTC) and biomarker technology , we are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. We invite companies with complementary technologies, innovative biomarkers, and special expertise in our field to explore partnering relationships. Academic associations help guide us in our research and expand our scientific knowledge. Researchers specializing in cancer biomarkers, circulating tumor cells, cancer biology, and personalized cancer care are encouraged to contact us. In addition, we welcome the opportunity to work with companies developing novel cancer therapies where we can advance the understanding of mechanisms of action, develop pharmaco-dynamic markers, patient stratification strategies to maximize chances of success, and companion biomarkers to optimize therapeutic efficacy and cost-effectiveness. Contact us today to learn more about the benefits of partnering with On-Q-ity.